Clinical and Immunological Changes of Immunotherapy in Patients with Atopic Dermatitis: Randomized Controlled Trial
Figure 3
Use of topical immunosuppressors in baseline and after 12 months of treatment. Points were assigned according to dose, frequency of use, and relative potency of the steroid used. Blue: Active Group. Red: Control Group. *;; Mann-Whitney test, Wilcoxon test.
